Annual CFF
$296.00 K
-$113.00 K-27.63%
December 31, 2023
Summary
- As of February 7, 2025, CLPT annual cash flow from financing activities is $296.00 thousand, with the most recent change of -$113.00 thousand (-27.63%) on December 31, 2023.
- During the last 3 years, CLPT annual CFF has fallen by -$22.40 million (-98.70%).
- CLPT annual CFF is now -99.37% below its all-time high of $46.88 million, reached on December 31, 2021.
Performance
CLPT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$10.06 M
-$10.22 M-6388.13%
September 30, 2024
Summary
- As of February 7, 2025, CLPT quarterly cash flow from financing activities is -$10.06 million, with the most recent change of -$10.22 million (-6388.13%) on September 30, 2024.
- Over the past year, CLPT quarterly CFF has dropped by -$9.97 million (-10956.04%).
- CLPT quarterly CFF is now -121.44% below its all-time high of $46.93 million, reached on March 31, 2021.
Performance
CLPT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.31 M
-$9.97 M-61.25%
September 30, 2024
Summary
- As of February 7, 2025, CLPT TTM cash flow from financing activities is $6.31 million, with the most recent change of -$9.97 million (-61.25%) on September 30, 2024.
- Over the past year, CLPT TTM CFF has increased by +$5.94 million (+1637.47%).
- CLPT TTM CFF is now -88.65% below its all-time high of $55.57 million, reached on March 31, 2021.
Performance
CLPT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CLPT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.6% | -10000.0% | +1637.5% |
| 3 y3 years | -98.7% | -2125.9% | -88.5% |
| 5 y5 years | +119.8% | -3889.3% | +12.5% |
CLPT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.4% | at low | -162.7% | at low | -86.5% | >+9999.0% |
| 5 y | 5-year | -99.4% | at low | -121.4% | at low | -88.7% | >+9999.0% |
| alltime | all time | -99.4% | +119.8% | -121.4% | at low | -88.7% | +471.0% |
ClearPoint Neuro Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.06 M(-6388.1%) | $6.31 M(-61.3%) |
| Jun 2024 | - | $160.00 K(-99.0%) | $16.28 M(-0.5%) |
| Mar 2024 | - | $16.05 M(>+9900.0%) | $16.35 M(+5425.0%) |
| Dec 2023 | $296.00 K(-27.6%) | $155.00 K(-270.3%) | $296.00 K(-18.5%) |
| Sep 2023 | - | -$91.00 K(-138.4%) | $363.00 K(+190.4%) |
| Jun 2023 | - | $237.00 K(-4840.0%) | $125.00 K(-68.8%) |
| Mar 2023 | - | -$5000.00(-102.3%) | $401.00 K(-2.0%) |
| Dec 2022 | $409.00 K(-99.1%) | $222.00 K(-167.5%) | $409.00 K(+74.0%) |
| Sep 2022 | - | -$329.00 K(-164.1%) | $235.00 K(+109.8%) |
| Jun 2022 | - | $513.00 K(>+9900.0%) | $112.00 K(-315.4%) |
| Mar 2022 | - | $3000.00(-93.8%) | -$52.00 K(-100.1%) |
| Dec 2021 | $46.88 M(+106.6%) | $48.00 K(-110.6%) | $46.88 M(-14.3%) |
| Sep 2021 | - | -$452.00 K(-229.5%) | $54.70 M(-0.8%) |
| Jun 2021 | - | $349.00 K(-99.3%) | $55.16 M(-0.7%) |
| Mar 2021 | - | $46.93 M(+495.9%) | $55.57 M(+144.9%) |
| Dec 2020 | $22.69 M(+304.9%) | $7.88 M(>+9900.0%) | $22.69 M(+53.9%) |
| Sep 2020 | - | $0.00(-100.0%) | $14.74 M(+1.7%) |
| Jun 2020 | - | $764.00 K(-94.6%) | $14.49 M(-26.3%) |
| Mar 2020 | - | $14.05 M(<-9900.0%) | $19.66 M(+250.7%) |
| Dec 2019 | $5.61 M(-475.0%) | -$72.90 K(-71.1%) | $5.61 M(-0.8%) |
| Sep 2019 | - | -$252.20 K(-104.3%) | $5.65 M(+44.8%) |
| Jun 2019 | - | $5.93 M(>+9900.0%) | $3.90 M(-329.6%) |
| Mar 2019 | - | $0.00(-100.0%) | -$1.70 M(+13.7%) |
| Dec 2018 | -$1.49 M | -$26.60 K(-98.7%) | -$1.49 M(+2.4%) |
| Sep 2018 | - | -$2.00 M(-712.0%) | -$1.46 M(-374.5%) |
| Jun 2018 | - | $326.80 K(+59.3%) | $531.70 K(-95.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $205.10 K(+2230.7%) | $12.20 M(+1.7%) |
| Dec 2017 | $11.99 M(+213.3%) | $8800.00(-197.8%) | $11.99 M(+0.1%) |
| Sep 2017 | - | -$9000.00(-100.1%) | $11.98 M(-24.3%) |
| Jun 2017 | - | $11.99 M(>+9900.0%) | $15.82 M(+298.7%) |
| Mar 2017 | - | $0.00(-100.0%) | $3.97 M(+3.7%) |
| Dec 2016 | $3.83 M(-21.5%) | -$4100.00(-100.1%) | $3.83 M(-56.1%) |
| Sep 2016 | - | $3.83 M(+2635.5%) | $8.71 M(+78.5%) |
| Jun 2016 | - | $140.10 K(-200.0%) | $4.88 M(+3.0%) |
| Mar 2016 | - | -$140.10 K(-102.9%) | $4.74 M(-2.9%) |
| Dec 2015 | $4.88 M(-62.5%) | $4.88 M(>+9900.0%) | $4.88 M(-48.0%) |
| Sep 2015 | - | $0.00(0.0%) | $9.38 M(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $9.38 M(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) | $9.38 M(-28.0%) |
| Dec 2014 | $13.03 M(+32.3%) | $9.38 M(>+9900.0%) | $13.03 M(+257.2%) |
| Sep 2014 | - | $0.00(0.0%) | $3.65 M(-0.2%) |
| Jun 2014 | - | $0.00(-100.0%) | $3.65 M(-0.4%) |
| Mar 2014 | - | $3.65 M(>+9900.0%) | $3.67 M(-62.8%) |
| Dec 2013 | $9.85 M(+9.0%) | $0.00(-100.0%) | $9.85 M(-0.9%) |
| Sep 2013 | - | $6300.00(-53.0%) | $9.94 M(-31.3%) |
| Jun 2013 | - | $13.40 K(-99.9%) | $14.46 M(-6.3%) |
| Mar 2013 | - | $9.83 M(>+9900.0%) | $15.44 M(+70.9%) |
| Dec 2012 | $9.04 M(+86.9%) | $93.80 K(-97.9%) | $9.04 M(+1.0%) |
| Sep 2012 | - | $4.53 M(+357.6%) | $8.94 M(+102.6%) |
| Jun 2012 | - | $989.50 K(-71.1%) | $4.41 M(+28.9%) |
| Mar 2012 | - | $3.42 M | $3.42 M |
| Dec 2011 | $4.83 M(-28.7%) | - | - |
| Dec 2010 | $6.78 M | - | - |
FAQ
- What is ClearPoint Neuro annual cash flow from financing activities?
- What is the all time high annual CFF for ClearPoint Neuro?
- What is ClearPoint Neuro annual CFF year-on-year change?
- What is ClearPoint Neuro quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly CFF year-on-year change?
- What is ClearPoint Neuro TTM cash flow from financing activities?
- What is the all time high TTM CFF for ClearPoint Neuro?
- What is ClearPoint Neuro TTM CFF year-on-year change?
What is ClearPoint Neuro annual cash flow from financing activities?
The current annual CFF of CLPT is $296.00 K
What is the all time high annual CFF for ClearPoint Neuro?
ClearPoint Neuro all-time high annual cash flow from financing activities is $46.88 M
What is ClearPoint Neuro annual CFF year-on-year change?
Over the past year, CLPT annual cash flow from financing activities has changed by -$113.00 K (-27.63%)
What is ClearPoint Neuro quarterly cash flow from financing activities?
The current quarterly CFF of CLPT is -$10.06 M
What is the all time high quarterly CFF for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly cash flow from financing activities is $46.93 M
What is ClearPoint Neuro quarterly CFF year-on-year change?
Over the past year, CLPT quarterly cash flow from financing activities has changed by -$9.97 M (-10956.04%)
What is ClearPoint Neuro TTM cash flow from financing activities?
The current TTM CFF of CLPT is $6.31 M
What is the all time high TTM CFF for ClearPoint Neuro?
ClearPoint Neuro all-time high TTM cash flow from financing activities is $55.57 M
What is ClearPoint Neuro TTM CFF year-on-year change?
Over the past year, CLPT TTM cash flow from financing activities has changed by +$5.94 M (+1637.47%)